Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Piazza L. Miraglia 2, 80138, Naples, Italy.
Clinical Department of Laboratory Services and Public Health-Legal Medicine Unit, University of Campania "Luigi Vanvitelli", via Luciano Armanni 5, 80138, Naples, Italy.
Curr Neurol Neurosci Rep. 2022 Jan;22(1):47-69. doi: 10.1007/s11910-022-01172-z. Epub 2022 Feb 9.
The aim of this review is to provide a comprehensive update on the clinical assessment, diagnosis, complications, and treatment of primary central nervous system vasculitis (PCNSV).
The developments in neuroimaging, molecular testing, and cerebral biopsy have enhanced clinical assessment and decision making, providing novel insights to prevent misdiagnosis increasing diagnostic certainty. Advances in imaging techniques visualizing the wall of intracranial vessels have improved the possibility to distinguish inflammatory from non-inflammatory vascular lesions. Large recent studies have revealed a more varied histopathological pictures and disclosed an association with amyloid angiopathy. Unfortunately, therapy remains largely empiric. PCNSV is a heterogeneous group of disorders encompassing different clinical subsets that may differ in terms of prognosis and therapy. Recent evidence has described a more benign course, with good response to therapy. New diagnostic techniques will play soon a pivotal role in the appropriate diagnosis and prompt management of PCNSV.
本综述旨在提供原发性中枢神经系统血管炎(PCNSV)的临床评估、诊断、并发症和治疗的全面更新。
神经影像学、分子检测和脑活检的发展增强了临床评估和决策,为预防误诊、提高诊断确定性提供了新的见解。成像技术的进步可以观察颅内血管壁,提高了区分炎症性和非炎症性血管病变的可能性。最近的大型研究揭示了更具异质性的组织病理学图片,并发现与淀粉样血管病有关。不幸的是,治疗仍然主要是经验性的。PCNSV 是一组异质性疾病,包括不同的临床亚型,在预后和治疗方面可能存在差异。最近的证据描述了一个更良性的过程,对治疗有良好的反应。新的诊断技术将很快在 PCNSV 的适当诊断和及时治疗中发挥关键作用。